﻿<?xml version="1.0" encoding="utf-8"?>
<Return xmlns="http://www.irs.gov/efile" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" returnVersion="2011v1.2">
  <ReturnHeader binaryAttachmentCount="0">
    <Timestamp>2012-11-14T09:31:38-06:00</Timestamp>
    <TaxPeriodEndDate>2011-12-31</TaxPeriodEndDate>
    <PreparerFirm>
      <PreparerFirmBusinessName>
        <BusinessNameLine1>GRAVES &amp; COMPANY PC</BusinessNameLine1>
      </PreparerFirmBusinessName>
      <PreparerFirmUSAddress>
        <AddressLine1>20550 VERNIER RD</AddressLine1>
        <City>HARPER WOODS</City>
        <State>MI</State>
        <ZIPCode>482251413</ZIPCode>
      </PreparerFirmUSAddress>
    </PreparerFirm>
    <ReturnType>990</ReturnType>
    <TaxPeriodBeginDate>2011-01-01</TaxPeriodBeginDate>
    <Filer>
      <EIN>270097769</EIN>
      <Name>
        <BusinessNameLine1>EICOSANOID RESEARCH FOUNDATION</BusinessNameLine1>
        <BusinessNameLine2>C/O DR KENNETH V HONN</BusinessNameLine2>
      </Name>
      <NameControl>EICO</NameControl>
      <Phone>3135771018</Phone>
      <USAddress>
        <AddressLine1>5101 CASS AVE 431 CHEMISTRY BLDG</AddressLine1>
        <City>DETROIT</City>
        <State>MI</State>
        <ZIPCode>48202</ZIPCode>
      </USAddress>
    </Filer>
    <Officer>
      <Name>DR KENNETH V HONN</Name>
      <Title>DIRECTOR</Title>
      <Phone>3135771018</Phone>
      <DateSigned>2012-11-14</DateSigned>
      <AuthorizeThirdParty>true</AuthorizeThirdParty>
    </Officer>
    <Preparer>
      <Name>LAWRENCE B GRAVES JR CPA</Name>
      <Phone>3138868892</Phone>
      <DatePrepared>2012-11-14</DatePrepared>
    </Preparer>
    <TaxYear>2011</TaxYear>
    <BuildTS>2016-02-24 21:20:13Z</BuildTS>
  </ReturnHeader>
  <ReturnData documentCount="5">
    <IRS990 documentId="RetDoc3" referenceDocumentId="RetDoc5">
      <NameOfPrincipalOfficerPerson>DR KENNETH V HONN</NameOfPrincipalOfficerPerson>
      <AddressPrincipalOfficerUS>
        <AddressLine1>5101 CASS AVE 431 CHEMISTRY BLDG</AddressLine1>
        <City>DETROIT</City>
        <State>MI</State>
        <ZIPCode>48202</ZIPCode>
      </AddressPrincipalOfficerUS>
      <GrossReceipts>301527</GrossReceipts>
      <GroupReturnForAffiliates>false</GroupReturnForAffiliates>
      <Organization501c3>X</Organization501c3>
      <WebSite>WWW.EICOSANOIDRESEARCHFOUNDATION.ORG</WebSite>
      <TypeOfOrganizationCorporation>X</TypeOfOrganizationCorporation>
      <YearFormation>2004</YearFormation>
      <StateLegalDomicile>MI</StateLegalDomicile>
      <ActivityOrMissionDescription>THE PURPOSE OF THE EICOSANOID RESEARCH FOUNDATION (ERF) IS TO PROVIDE A FORUM FOR THE DISSEMINATION OF THE LATEST SCIENTIFIC INFORMATION ON BIOACTIVE LIPIDS IN HEALTH AND DISEASE AS IT RELATES TO CANCER, INFLAMATION AND INFLAMATION INDUCED DISEASES SUCH AS CARDIOVASCULAR, DIABETES, PSORIASIS AND ALZHEIMER'S. THE EICOSANOID RESEARCH FOUNDATION SPONSORS BI-ANNUAL CONFERENCES HIGHLIGHTING DATA AT THE CUTTING EDGE OF MEDICAL SCIENCE. DURING THESE CONFERENCES NEW DRUGS AND MEDICATIONS ARE DISCUSSED, DATA ON CLINICAL TRIALS IS EXAMINED AND SCIENTISTS INTERACT TO ENHANCE THEIR COLLABORATIVE RESEARCH EFFORTS. THE GOAL OF THIS MEETING SERIES IS TO PROMOTE THE EXCHANGE OF INFORMATION AND IDEAS AMOUNG SCIENTISTS OF DIVERSE BACKGROUNDS FROM AROUND THE WORLD. THE SOLE PURPOSE OF THE EICOSANOID RESEARCH FOUNDATION IS TO RAISE FUNDS TO SPONSOR THE INTERNATIONAL CONFERENCE ON BIOACTIVE LIPIDS IN CANCER, INFLAMMATION AND RELATED DISEASES THEREBY PROMOTING ADVANCES IN THIS AREA OF SCIENCE AND MEDICAL RE</ActivityOrMissionDescription>
      <NbrVotingMembersGoverningBody>4</NbrVotingMembersGoverningBody>
      <NbrIndependentVotingMembers>0</NbrIndependentVotingMembers>
      <TotalNbrEmployees>0</TotalNbrEmployees>
      <TotalGrossUBI>0</TotalGrossUBI>
      <ContributionsGrantsCurrentYear>197850</ContributionsGrantsCurrentYear>
      <ProgramServiceRevenueCY>103667</ProgramServiceRevenueCY>
      <InvestmentIncomeCurrentYear>10</InvestmentIncomeCurrentYear>
      <OtherRevenueCurrentYear>0</OtherRevenueCurrentYear>
      <TotalRevenueCurrentYear>301527</TotalRevenueCurrentYear>
      <GrantsAndSimilarAmntsCY>25000</GrantsAndSimilarAmntsCY>
      <BenefitsPaidToMembersCY>0</BenefitsPaidToMembersCY>
      <SalariesEtcCurrentYear>0</SalariesEtcCurrentYear>
      <TotalProfFundrsngExpCY>0</TotalProfFundrsngExpCY>
      <TotalFundrsngExpCurrentYear>0</TotalFundrsngExpCurrentYear>
      <OtherExpensesCurrentYear>278402</OtherExpensesCurrentYear>
      <TotalExpensesCurrentYear>303402</TotalExpensesCurrentYear>
      <RevenuesLessExpensesCY>-1875</RevenuesLessExpensesCY>
      <TotalAssetsBOY>67437</TotalAssetsBOY>
      <TotalAssetsEOY>65562</TotalAssetsEOY>
      <TotalLiabilitiesEOY>0</TotalLiabilitiesEOY>
      <NetAssetsOrFundBalancesBOY>67437</NetAssetsOrFundBalancesBOY>
      <NetAssetsOrFundBalancesEOY>65562</NetAssetsOrFundBalancesEOY>
      <InfoInScheduleOPartIII>X</InfoInScheduleOPartIII>
      <MissionDescription>THE PURPOSE OF THE EICOSANOID RESEARCH FOUNDATION (ERF) IS TO PROVIDE A FORUM FOR THE DISSEMINATION OF THE LATEST SCIENTIFIC INFORMATION ON BIOACTIVE LIPIDS IN HEALTH AND DISEASE AS IT RELATES TO CANCER, INFLAMATION AND INFLAMATION INDUCED DISEASES SUCH AS CARDIOVASCULAR, DIABETES, PSORIASIS AND ALZHEIMER'S. THE EICOSANOID RESEARCH FOUNDATION SPONSORS BI-ANNUAL CONFERENCES HIGHLIGHTING DATA AT THE CUTTING EDGE OF MEDICAL SCIENCE. DURING THESE CONFERENCES NEW DRUGS AND MEDICATIONS ARE DISCUSSED, DATA ON CLINICAL TRIALS IS EXAMINED AND SCIENTISTS INTERACT TO ENHANCE THEIR COLLABORATIVE RESEARCH EFFORTS. THE GOAL OF THIS MEETING SERIES IS TO PROMOTE THE EXCHANGE OF INFORMATION AND IDEAS AMOUNG SCIENTISTS OF DIVERSE BACKGROUNDS FROM AROUND THE WORLD. THE SOLE PURPOSE OF THE EICOSANOID RESEARCH FOUNDATION IS TO RAISE FUNDS TO SPONSOR THE INTERNATIONAL CONFERENCE ON BIOACTIVE LIPIDS IN CANCER, INFLAMMATION AND RELATED DISEASES THEREBY PROMOTING ADVANCES IN THIS AREA OF SCIENCE AND MEDICAL RE</MissionDescription>
      <SignificantNewProgramServices>false</SignificantNewProgramServices>
      <SignificantChange>false</SignificantChange>
      <Expense>289634</Expense>
      <Grants>25000</Grants>
      <Description>THE ORGANIZATION HELD AN INFORMATIVE AND SUCCESSFUL CONFERENCE IN THE FALL OF 2011 RELATING TO THE DISSEMINATION OF THE LATEST SCIENTIFIC AND MEDICAL INFORMATION ON BIOACTIVE LIPIDS IN HEALTH AND DISEASE, AS THEY RELATE TO CANCER. THE CONFERENCE SUCCESSFULLY PROMOTED THE EXCHANGE OF IDEAS AND THEORIES IN THIS AREA AMOUNG SCIENTISTS AND MEDICAL PROFESSIONALS AROUND THE WORLD, IN AN EFFORT TO FIND A CURE FOR CANCER. THE ORGANIZATION IS CURRENTLY PLANNING ITS 2013 BI-ANNUAL CONFERENCE TO BE HELD IN SAN JUAN PUERTO RICO.</Description>
      <TotalProgramServiceExpense>289634</TotalProgramServiceExpense>
      <DescribedIn501C3 referenceDocumentId="RetDoc2">true</DescribedIn501C3>
      <ScheduleBRequired referenceDocumentId="RetDoc1">true</ScheduleBRequired>
      <PoliticalActivities>false</PoliticalActivities>
      <LobbyingActivities>false</LobbyingActivities>
      <SubjectToProxyTax>false</SubjectToProxyTax>
      <DonorAdvisedFunds>false</DonorAdvisedFunds>
      <ConservationEasements>false</ConservationEasements>
      <CollectionsOfArt>false</CollectionsOfArt>
      <CreditCounseling>false</CreditCounseling>
      <TermOrPermanentEndowments>false</TermOrPermanentEndowments>
      <ReportLandBldgEquip>false</ReportLandBldgEquip>
      <ReportInvestOthSecurities>false</ReportInvestOthSecurities>
      <ReportProgRelInvest>false</ReportProgRelInvest>
      <ReportOtherAssets>false</ReportOtherAssets>
      <ReportOtherLiabilities>false</ReportOtherLiabilities>
      <ReportFin48Footnote>false</ReportFin48Footnote>
      <IndependentAuditFinancialStmt>false</IndependentAuditFinancialStmt>
      <ConsolidatedAuditFinancialStmt>false</ConsolidatedAuditFinancialStmt>
      <School>false</School>
      <ForeignOffice>false</ForeignOffice>
      <ForeignActivities>false</ForeignActivities>
      <MoreThan5000KToOrganizations>false</MoreThan5000KToOrganizations>
      <MoreThan5000KToIndividuals>false</MoreThan5000KToIndividuals>
      <ProfessionalFundraising>false</ProfessionalFundraising>
      <FundraisingActivities>false</FundraisingActivities>
      <Gaming>false</Gaming>
      <Hospital>false</Hospital>
      <GrantsToOrganizations referenceDocumentId="RetDoc4">true</GrantsToOrganizations>
      <GrantsToIndividuals referenceDocumentId="RetDoc4">false</GrantsToIndividuals>
      <ScheduleJRequired>false</ScheduleJRequired>
      <TaxExemptBonds>false</TaxExemptBonds>
      <ExcessBenefitTransaction>false</ExcessBenefitTransaction>
      <PriorExcessBenefitTransaction>false</PriorExcessBenefitTransaction>
      <LoanToOfficerOrDQP>false</LoanToOfficerOrDQP>
      <GrantToRelatedPerson>false</GrantToRelatedPerson>
      <BsnssRltnshpWithOrganization>false</BsnssRltnshpWithOrganization>
      <BsnssRltnshpThruFamilyMember>false</BsnssRltnshpThruFamilyMember>
      <OfficerEntityWithBsnssRltnshp>false</OfficerEntityWithBsnssRltnshp>
      <DeductibleNonCashContributions>false</DeductibleNonCashContributions>
      <DeductibleContributionsOfArt>false</DeductibleContributionsOfArt>
      <Terminated>false</Terminated>
      <PartialLiquidation>false</PartialLiquidation>
      <DisregardedEntity>false</DisregardedEntity>
      <RelatedEntity>false</RelatedEntity>
      <RelatedOrgControlledEntity>false</RelatedOrgControlledEntity>
      <TransactionRelatedEntity>false</TransactionRelatedEntity>
      <TransfersToExemptNonChrtblOrg>false</TransfersToExemptNonChrtblOrg>
      <ActivitiesConductedPartnership>false</ActivitiesConductedPartnership>
      <ScheduleORequired>false</ScheduleORequired>
      <NumberFormsTransmittedWith1096>2</NumberFormsTransmittedWith1096>
      <NumberW2GIncluded>0</NumberW2GIncluded>
      <NumberOfEmployees>0</NumberOfEmployees>
      <UnrelatedBusinessIncome>false</UnrelatedBusinessIncome>
      <ForeignFinancialAccount>false</ForeignFinancialAccount>
      <ProhibitedTaxShelterTrans>false</ProhibitedTaxShelterTrans>
      <TaxablePartyNotification>false</TaxablePartyNotification>
      <NonDeductibleContributions>false</NonDeductibleContributions>
      <IndoorTanningServices>false</IndoorTanningServices>
      <InfoInScheduleOPartVI>X</InfoInScheduleOPartVI>
      <NbrVotingGoverningBodyMembers>4</NbrVotingGoverningBodyMembers>
      <NumberIndependentVotingMembers>0</NumberIndependentVotingMembers>
      <FamilyOrBusinessRelationship>false</FamilyOrBusinessRelationship>
      <DelegationOfManagementDuties>false</DelegationOfManagementDuties>
      <ChangesToOrganizingDocs>false</ChangesToOrganizingDocs>
      <MaterialDiversionOrMisuse>false</MaterialDiversionOrMisuse>
      <MembersOrStockholders>false</MembersOrStockholders>
      <ElectionOfBoardMembers>false</ElectionOfBoardMembers>
      <DecisionsSubjectToApproval>false</DecisionsSubjectToApproval>
      <MinutesOfGoverningBody>true</MinutesOfGoverningBody>
      <MinutesOfCommittees>true</MinutesOfCommittees>
      <OfficerMailingAddress>false</OfficerMailingAddress>
      <LocalChapters>false</LocalChapters>
      <Form990ProvidedToGoverningBody>false</Form990ProvidedToGoverningBody>
      <ConflictOfInterestPolicy>false</ConflictOfInterestPolicy>
      <WhistleblowerPolicy>false</WhistleblowerPolicy>
      <DocumentRetentionPolicy>false</DocumentRetentionPolicy>
      <CompensationProcessCEO>false</CompensationProcessCEO>
      <CompensationProcessOther>false</CompensationProcessOther>
      <InvestmentInJointVenture>false</InvestmentInJointVenture>
      <StatesWhereCopyOfReturnIsFiled>MI</StatesWhereCopyOfReturnIsFiled>
      <UponRequest>X</UponRequest>
      <TheBooksAreInCareOf>
        <NamePerson>CHRISTOPHER HARRIS</NamePerson>
        <TelephoneNumber>3135771018</TelephoneNumber>
        <AddressUS>
          <AddressLine1>5101 CASS AVENUE</AddressLine1>
          <City>DETROIT</City>
          <State>MI</State>
          <ZIPCode>48202</ZIPCode>
        </AddressUS>
      </TheBooksAreInCareOf>
      <NoListedPersonsCompensated>X</NoListedPersonsCompensated>
      <Form990PartVIISectionA>
        <NamePerson>DR KENNETH V HONN</NamePerson>
        <Title>DIRECTOR</Title>
        <AverageHoursPerWeek>3.00</AverageHoursPerWeek>
        <IndividualTrusteeOrDirector>X</IndividualTrusteeOrDirector>
        <ReportableCompFromOrganization>0</ReportableCompFromOrganization>
        <ReportableCompFromRelatedOrgs>0</ReportableCompFromRelatedOrgs>
        <OtherCompensation>0</OtherCompensation>
      </Form990PartVIISectionA>
      <Form990PartVIISectionA>
        <NamePerson>DR EDWARD DENNIS</NamePerson>
        <Title>DIRECTOR</Title>
        <AverageHoursPerWeek>2.00</AverageHoursPerWeek>
        <IndividualTrusteeOrDirector>X</IndividualTrusteeOrDirector>
        <ReportableCompFromOrganization>0</ReportableCompFromOrganization>
        <ReportableCompFromRelatedOrgs>0</ReportableCompFromRelatedOrgs>
        <OtherCompensation>0</OtherCompensation>
      </Form990PartVIISectionA>
      <Form990PartVIISectionA>
        <NamePerson>DR LARRY MARNETT</NamePerson>
        <Title>DIRECTOR</Title>
        <AverageHoursPerWeek>3.00</AverageHoursPerWeek>
        <IndividualTrusteeOrDirector>X</IndividualTrusteeOrDirector>
        <ReportableCompFromOrganization>0</ReportableCompFromOrganization>
        <ReportableCompFromRelatedOrgs>0</ReportableCompFromRelatedOrgs>
        <OtherCompensation>0</OtherCompensation>
      </Form990PartVIISectionA>
      <Form990PartVIISectionA>
        <NamePerson>DR CHARLES SERHAN</NamePerson>
        <Title>DIRECTOR</Title>
        <AverageHoursPerWeek>2.00</AverageHoursPerWeek>
        <IndividualTrusteeOrDirector>X</IndividualTrusteeOrDirector>
        <ReportableCompFromOrganization>0</ReportableCompFromOrganization>
        <ReportableCompFromRelatedOrgs>0</ReportableCompFromRelatedOrgs>
        <OtherCompensation>0</OtherCompensation>
      </Form990PartVIISectionA>
      <FormersListed>false</FormersListed>
      <TotalCompGT150K>false</TotalCompGT150K>
      <CompensationFromOtherSources>false</CompensationFromOtherSources>
      <AllOtherContributions>197850</AllOtherContributions>
      <TotalContributions>197850</TotalContributions>
      <ProgramServiceRevenue>
        <Description>CONFERENCE REGISTRATION FEES</Description>
        <TotalRevenueColumn>95267</TotalRevenueColumn>
        <RelatedOrExemptFunctionIncome>95267</RelatedOrExemptFunctionIncome>
      </ProgramServiceRevenue>
      <ProgramServiceRevenue>
        <Description>EXHIBITOR RECEIPTS</Description>
        <TotalRevenueColumn>6500</TotalRevenueColumn>
        <RelatedOrExemptFunctionIncome>6500</RelatedOrExemptFunctionIncome>
      </ProgramServiceRevenue>
      <ProgramServiceRevenue>
        <Description>ADVERTISING RECEIPTS</Description>
        <TotalRevenueColumn>1900</TotalRevenueColumn>
        <RelatedOrExemptFunctionIncome>1900</RelatedOrExemptFunctionIncome>
      </ProgramServiceRevenue>
      <TotalProgramServiceRevenue>103667</TotalProgramServiceRevenue>
      <InvestmentIncome>
        <TotalRevenueColumn>10</TotalRevenueColumn>
        <RelatedOrExemptFunctionIncome>10</RelatedOrExemptFunctionIncome>
      </InvestmentIncome>
      <TotalRevenue>
        <TotalRevenueColumn>301527</TotalRevenueColumn>
        <RelatedOrExemptFunctionIncome>103677</RelatedOrExemptFunctionIncome>
      </TotalRevenue>
      <GrantsToDomesticOrgs>
        <Total>25000</Total>
        <ProgramServices>25000</ProgramServices>
      </GrantsToDomesticOrgs>
      <FeesForServicesAccounting>
        <Total>2515</Total>
        <ManagementAndGeneral>2515</ManagementAndGeneral>
      </FeesForServicesAccounting>
      <OfficeExpenses>
        <Total>5190</Total>
        <ProgramServices>5190</ProgramServices>
      </OfficeExpenses>
      <Occupancy>
        <Total>210427</Total>
        <ProgramServices>210427</ProgramServices>
      </Occupancy>
      <Travel>
        <Total>12989</Total>
        <ProgramServices>12989</ProgramServices>
      </Travel>
      <OtherExpenses>
        <Description>SPEAKER HONORARIUMS</Description>
        <Total>16000</Total>
        <ProgramServices>16000</ProgramServices>
      </OtherExpenses>
      <OtherExpenses>
        <Description>TRAVEL/NIGAM AWARDS</Description>
        <Total>13000</Total>
        <ProgramServices>13000</ProgramServices>
      </OtherExpenses>
      <OtherExpenses>
        <Description>AWARD RELATED EXPENSES</Description>
        <Total>7028</Total>
        <ProgramServices>7028</ProgramServices>
      </OtherExpenses>
      <OtherExpenses>
        <Description>WEBSITE/COMPUTER EXPENSES</Description>
        <Total>5568</Total>
        <ManagementAndGeneral>5568</ManagementAndGeneral>
      </OtherExpenses>
      <AllOtherExpenses>
        <Total>5685</Total>
        <ManagementAndGeneral>5685</ManagementAndGeneral>
      </AllOtherExpenses>
      <TotalFunctionalExpenses>
        <Total>303402</Total>
        <ProgramServices>289634</ProgramServices>
        <ManagementAndGeneral>13768</ManagementAndGeneral>
        <Fundraising>0</Fundraising>
      </TotalFunctionalExpenses>
      <SavingsAndTempCashInvestments>
        <BOY>38437</BOY>
        <EOY>65562</EOY>
      </SavingsAndTempCashInvestments>
      <PrepaidExpensesDeferredCharges>
        <BOY>29000</BOY>
      </PrepaidExpensesDeferredCharges>
      <TotalAssets>
        <BOY>67437</BOY>
        <EOY>65562</EOY>
      </TotalAssets>
      <TotalLiabilities>
        <BOY>0</BOY>
        <EOY>0</EOY>
      </TotalLiabilities>
      <FollowSFAS117>X</FollowSFAS117>
      <UnrestrictedNetAssets>
        <BOY>67437</BOY>
        <EOY>65562</EOY>
      </UnrestrictedNetAssets>
      <TotalNetAssetsFundBalances>
        <BOY>67437</BOY>
        <EOY>65562</EOY>
      </TotalNetAssetsFundBalances>
      <TotalLiabNetAssetsFundBalances>
        <BOY>67437</BOY>
        <EOY>65562</EOY>
      </TotalLiabNetAssetsFundBalances>
      <ReconcilationRevenueExpenses>-1875</ReconcilationRevenueExpenses>
      <MethodOfAccountingCash>X</MethodOfAccountingCash>
      <AccountantCompileOrReview>false</AccountantCompileOrReview>
      <FSAudited>false</FSAudited>
    </IRS990>
    <IRS990ScheduleA documentId="RetDoc2">
      <PubliclySupportedOrg509a2>X</PubliclySupportedOrg509a2>
      <GiftsGrantsContribReceived509>
        <CurrentTaxYearMinus4Years>75345</CurrentTaxYearMinus4Years>
        <CurrentTaxYearMinus3Years>5000</CurrentTaxYearMinus3Years>
        <CurrentTaxYearMinus2Years>93793</CurrentTaxYearMinus2Years>
        <CurrentTaxYearMinus1Year>156500</CurrentTaxYearMinus1Year>
        <CurrentTaxYear>197850</CurrentTaxYear>
        <Total>528488</Total>
      </GiftsGrantsContribReceived509>
      <GrossReceiptsFromAdmissions>
        <CurrentTaxYearMinus4Years>138153</CurrentTaxYearMinus4Years>
        <CurrentTaxYearMinus2Years>91576</CurrentTaxYearMinus2Years>
        <CurrentTaxYear>103667</CurrentTaxYear>
        <Total>333396</Total>
      </GrossReceiptsFromAdmissions>
      <Total509>
        <CurrentTaxYearMinus4Years>213498</CurrentTaxYearMinus4Years>
        <CurrentTaxYearMinus3Years>5000</CurrentTaxYearMinus3Years>
        <CurrentTaxYearMinus2Years>185369</CurrentTaxYearMinus2Years>
        <CurrentTaxYearMinus1Year>156500</CurrentTaxYearMinus1Year>
        <CurrentTaxYear>301517</CurrentTaxYear>
        <Total>861884</Total>
      </Total509>
      <AmtsFromSubstContributors>
        <CurrentTaxYearMinus4Years>133153</CurrentTaxYearMinus4Years>
        <CurrentTaxYearMinus2Years>86576</CurrentTaxYearMinus2Years>
        <CurrentTaxYear>98667</CurrentTaxYear>
        <Total>318396</Total>
      </AmtsFromSubstContributors>
      <SupportFromDQPsEtc>
        <CurrentTaxYearMinus4Years>133153</CurrentTaxYearMinus4Years>
        <CurrentTaxYearMinus2Years>86576</CurrentTaxYearMinus2Years>
        <CurrentTaxYear>98667</CurrentTaxYear>
        <Total>318396</Total>
      </SupportFromDQPsEtc>
      <PublicSupportTotal509>543488</PublicSupportTotal509>
      <GrossInvestmentIncome509>
        <CurrentTaxYearMinus4Years>1116</CurrentTaxYearMinus4Years>
        <CurrentTaxYearMinus3Years>6</CurrentTaxYearMinus3Years>
        <CurrentTaxYearMinus2Years>8</CurrentTaxYearMinus2Years>
        <CurrentTaxYearMinus1Year>1</CurrentTaxYearMinus1Year>
        <CurrentTaxYear>10</CurrentTaxYear>
        <Total>1141</Total>
      </GrossInvestmentIncome509>
      <InvestmentIncomeAndUBTI>
        <CurrentTaxYearMinus4Years>1116</CurrentTaxYearMinus4Years>
        <CurrentTaxYearMinus3Years>6</CurrentTaxYearMinus3Years>
        <CurrentTaxYearMinus2Years>8</CurrentTaxYearMinus2Years>
        <CurrentTaxYearMinus1Year>1</CurrentTaxYearMinus1Year>
        <CurrentTaxYear>10</CurrentTaxYear>
        <Total>1141</Total>
      </InvestmentIncomeAndUBTI>
      <TotalSupportTotal>
        <CurrentTaxYearMinus4Years>214614</CurrentTaxYearMinus4Years>
        <CurrentTaxYearMinus3Years>5006</CurrentTaxYearMinus3Years>
        <CurrentTaxYearMinus2Years>185377</CurrentTaxYearMinus2Years>
        <CurrentTaxYearMinus1Year>156501</CurrentTaxYearMinus1Year>
        <CurrentTaxYear>301527</CurrentTaxYear>
        <Total>863025</Total>
      </TotalSupportTotal>
      <PublicSupportPercentage509>0.62970</PublicSupportPercentage509>
      <PriorYearSupportPercentage>0.60740</PriorYearSupportPercentage>
      <InvestmentIncomePercentage>0.00000</InvestmentIncomePercentage>
      <ThirtyThreePercntTestsCY509>X</ThirtyThreePercntTestsCY509>
    </IRS990ScheduleA>
    <IRS990ScheduleB documentId="RetDoc1">
      <ContributorInfo>
        <ContributorNumber>RESTRICTED</ContributorNumber>
        <ContributorNameBusiness>
          <BusinessNameLine1>RESTRICTED</BusinessNameLine1>
        </ContributorNameBusiness>
        <ContributorAddressUS>
          <AddressLine1>RESTRICTED</AddressLine1>
          <AddressLine2>RESTRICTED</AddressLine2>
          <City>RESTRICTED</City>
          <State>RESTRICTED</State>
          <ZIPCode>RESTRICTED</ZIPCode>
        </ContributorAddressUS>
        <AggregateContributions>RESTRICTED</AggregateContributions>
      </ContributorInfo>
    </IRS990ScheduleB>
    <IRS990ScheduleI documentId="RetDoc4">
      <RecordsMaintained>false</RecordsMaintained>
      <RecipientTable>
        <RecipientNameBusiness>
          <BusinessNameLine1>WAYNE STATE SCHOOL OF MEDICINE</BusinessNameLine1>
        </RecipientNameBusiness>
        <AddressUS>
          <AddressLine1>5475 WOODWARD AVENUE</AddressLine1>
          <City>DETROIT</City>
          <State>MI</State>
          <ZIPCode>48202</ZIPCode>
        </AddressUS>
        <EINOfRecipient>386028429</EINOfRecipient>
        <AmountOfCashGrant>25000</AmountOfCashGrant>
        <PurposeOfGrant>METASTASIS RESEARCH</PurposeOfGrant>
      </RecipientTable>
    </IRS990ScheduleI>
    <IRS990ScheduleO documentId="RetDoc5">
      <GeneralExplanation>
        <Identifier>ORGANIZATION'S MISSION</Identifier>
        <ReturnReference>FORM 990 - ORGANIZATION'S MISSION</ReturnReference>
        <Explanation>THE PURPOSE OF THE EICOSANOID RESEARCH FOUNDATION (ERF) IS TO PROVIDE A FORUM FOR THE DISSEMINATION OF THE LATEST SCIENTIFIC INFORMATION ON BIOACTIVE LIPIDS IN HEALTH AND DISEASE AS IT RELATES TO CANCER, INFLAMATION AND INFLAMATION INDUCED DISEASES SUCH AS CARDIOVASCULAR, DIABETES, PSORIASIS AND ALZHEIMER'S. THE EICOSANOID RESEARCH FOUNDATION SPONSORS BI-ANNUAL CONFERENCES HIGHLIGHTING DATA AT THE CUTTING EDGE OF MEDICAL SCIENCE. DURING THESE CONFERENCES NEW DRUGS AND MEDICATIONS ARE DISCUSSED, DATA ON CLINICAL TRIALS IS EXAMINED AND SCIENTISTS INTERACT TO ENHANCE THEIR COLLABORATIVE RESEARCH EFFORTS. THE GOAL OF THIS MEETING SERIES IS TO PROMOTE THE EXCHANGE OF INFORMATION AND IDEAS AMOUNG SCIENTISTS OF DIVERSE BACKGROUNDS FROM AROUND THE WORLD. THE SOLE PURPOSE OF THE EICOSANOID RESEARCH FOUNDATION IS TO RAISE FUNDS TO SPONSOR THE INTERNATIONAL CONFERENCE ON BIOACTIVE LIPIDS IN CANCER, INFLAMMATION AND RELATED DISEASES THEREBY PROMOTING ADVANCES IN THIS AREA OF SCIENCE AND MEDICAL RESEARCH.</Explanation>
      </GeneralExplanation>
      <GeneralExplanation>
        <Identifier>ORGANIZATION'S PROCESS USED TO REVIEW FORM 990</Identifier>
        <ReturnReference>FORM 990, PAGE 6, PART VI, LINE 11B</ReturnReference>
        <Explanation>NO REVIEW WAS OR WILL BE CONDUCTED.</Explanation>
      </GeneralExplanation>
      <GeneralExplanation>
        <Identifier>GOVERNING DOCUMENTS DISCLOSURE EXPLANATION</Identifier>
        <ReturnReference>FORM 990, PAGE 6, PART VI, LINE 19</ReturnReference>
        <Explanation>NO DOCUMENTS AVAILABLE TO THE PUBLIC</Explanation>
      </GeneralExplanation>
    </IRS990ScheduleO>
  </ReturnData>
</Return>